LexDanaLexDanabeta
Inventor

Wendy Lee

Inventor
Hamden, CT, US

Overview

39→
Patents
1994–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 39 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds46%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
A61KPreparations for medical, dental or toiletry purposes11%
C07CAcyclic or carbocyclic compounds4%
G06TImage data processing or generation, in general1%
H01LSemiconductor devices1%
H10PGeneric processes or apparatus for the manufacture or treatment of devices covered by class h101%
H10WGeneric packages, interconnections, connectors or other constructional details of devices covered by class h101%
PatentTitleYear
11,056,403Wafer with beveled edge region and method for analyzing shape of the same202110,766,903Piperidine derivatives as inhibitors of ubiquitin specific protease 720209,850,239Pyrazolo[3,4-c]pyridine compounds and methods of use20179,326,985'Heteroaryl pyridone and aza-pyridone amide compounds'20169,260,425'Pyrazolo[3,4-c]pyridine compounds and methods of use'20169,181,188'Aryl ureas as kinase inhibitors'20158,828,990'N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use'20148,815,877'Serine/threonine kinase inhibitors'20148,637,537'Serine/threonine kinase inhibitors'20148,580,798'Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders'20138,431,695'Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases'20138,288,408'5-anilinoimidazopyridines and methods of use'20128,288,381'N-9 substituted purine compounds, compositions and methods of use'20128,207,166'Substituted pyrazolyl urea derivatives useful in the treatment of cancer'20128,110,587'Aryl ureas as kinase inhibitors'20128,076,488'Bicyclic urea derivatives useful in the treatment of cancer and other disorders'20117,977,333'Substituted pyridines and pyridazines with angiogenesis inhibiting activity'20117,923,456'5-anilinoimidazo[1,5-a]-pyridines inhibitors of MEK kinase'20117,855,216'Aza-indolyl compounds and methods of use'20107,838,524'Substituted pyrazolyl urea derivatives useful in the treatment of cancer'20107,585,888'Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders'20097,557,129'Cyanopyridine derivatives useful in the treatment of cancer and other disorders'20097,384,947'Fused tricyclic heterocycles useful for treating hyper-proliferative disorders'20087,351,735'Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders'20087,144,885'Fused tricyclic heterocycles useful for treating hyper-proliferative disorders'20066,919,371'2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists'20056,903,101'Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity'20056,689,883'Substituted pyridines and pyridazines with angiogenesis inhibiting activity'20046,660,752'2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists'20036,187,799'Inhibition of raf kinase activity using aryl ureas'20015,840,758'Oxime derivatives of fenamates as inhibitors of prostaglandin biosynthesis'19985,750,558'Oxime derivatives of indole and indene compounds as inhibitors of prostaglandin biosynthesis'19985,484,786'Pyran-4-ylmethyl substituted arylalkylaryl-, arylalkenylylaryl-, and arylalkynylarylurea inhibitors of 5-lipoxygenase'19965,446,062'((4-alkoxypyran-4-yl) substituted) ether, arylalkyl-, arylalkenyl-, and arylalkynyl)urea inhibitors of 5-lipoxygenase'19955,432,194'(4-alkoxypyran-4-yl) substituted arylalkylaryl-, aryalkenylaryl-, and aryalkynylarylurea inhibitors of 5-lipoxygenase'19955,407,959'(Trans-1,4-dialkoxycyclohexyl) substituted arylalkylaryl-arylalkenylaryl-, and arylalkynylarylurea inhibitors of 5-lipoxygenase'19955,346,914'(4-alkoxypyran-4-yl) substituted arylalkylaryl-, arylalkenylaryl-, and arylalkynylarylurea inhibitors of 5-lipoxygenase'19945,336,674'2-phenanthridinyl carbaphenem antibacterial agent'19945,328,904'2-phenanthridinyl carbapenem antibacterial agents'1994

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1994–1998Patents assigned to ABBOTT LAB (7)· patent assignee history
1994–1996Based in Chicago, IL, US· patent location history
1998–2015Based in Hamden, CT, US· patent location history
2003–2009Patents assigned to BAYER PHARMACEUTICALS CORP (7)· patent assignee history
2008–2015Patents assigned to BAYER HEALTHCARE LLC (8)· patent assignee history
2010–2017Patents assigned to GENENTECH INC (10)· patent assignee history
2010–2017Based in San Ramon, CA, US· patent location history
2010–2012Based in South San Francisco, CA, US· patent location history
2011–2016Patents assigned to LEE WENDY (11)· patent assignee history
2021Based in Gyeongsangbuk-do, KR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LEE WENDYself112011–2016
GENENTECH INC102010–2017
BAYER HEALTHCARE LLC82008–2015
ABBOTT LAB71994–1998
BAYER PHARMACEUTICALS CORP72003–2009
Locations
LocationPatentsSpan
Hamden, CT, US161998–2015
San Ramon, California, US122010–2017
Chicago, Illinois, US71994–1996
South San Francisco, California, US22010–2012
Gyeongsangbuk-do, KR12021